NOVT compared with VCEL: revenue, margins and what each company keeps, and the suppliers and customers both name

NOVTNovanta Inc

Mkt capRevenueRevenue

VCELVericel Corp

Mkt capRevenueRevenue

Compare

NOVTNovanta Inc

VCELVericel Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

NOVTNovanta Inc

145.58▼−3.71%· post 144.39

Mkt cap$5.5BRevenue$266MQ2 FY26Revenue$981MFY25

VCELVericel Corp

40.22▼−6.27%· post 40.22

ClosedOct 30 '26

Mkt cap$2.1BRevenue$77MQ2 FY26Revenue$276MFY25

Compare

ClosedOct 30 '26

NOVTNovanta Inc

VCELVericel Corp

145.58▼−3.71%post 144.39

Price

40.22▼−6.27%post 40.22

$5.5B

Mkt cap

$2.1B

Q2 FY26$266M

Revenue

$77MQ2 FY26

FY25$981M

Revenue

$276MFY25

NOVT145.58▼−3.71%vsVCEL40.22▼−6.27%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

NOVT, solidVCEL, dashed

Supply-chain overlap

Revenue flow

VCEL: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NOVT 0

None

Shared 0

No disclosed counterparties: NOVT.

Only VCEL 5

—Matricel GmbHunlistedsupplier

—MediWoundunlistedsupplier

—AllCare Plus Pharmacyunlistedsupplier

—Orsini Pharmaceutical Servicesunlistedsupplier

1 more · VCEL chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR